CASI Pharmaceuticals, Inc. Ordinary Shares (CASI) Stock Price

CASIStock
$0.00−27.08%52W
Market Cap—
P/E—
PEG Ratio—
Div yield—
Beta-0.38

CASI Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)29.06%
Price vs S&P 500 (4W)-80.09%
VGM Score58.80

CASI Analyst Recommendations

Mar 2023
Apr 2023
May 2023
Jun 2023
4.25
4.25
4.25
4.14

About CASI Pharmaceuticals, Inc. Ordinary Shares

CASI Pharmaceuticals is a specialized biopharmaceutical company focused on oncology therapies for hematologic malignancies including leukemia, lymphoma, and multiple myeloma. The company's marketed products include EVOMELA, a conditioning agent for autologous stem cell transplant in multiple myeloma patients, along with MARQIBO and ZEVALIN. EVOMELA is the primary revenue driver.